Title: |
Chinese Guidelines for diagnosis and treatment of BCG adverse reactions |
Edition: |
Original |
Classification: |
Standard guideline |
Field: |
Comprehensive guideline |
Countries and regions: |
China |
Guidelines users: |
Paediatrics, infectious diseases, tuberculosis, urology, oncology and transplantation doctors, public health workers and related nursing staff. |
Evidence classification method: |
GRADE |
Development unit: |
Tuberculosis Branch of Chinese Medical Association, School and children tuberculosis branch of China Tuberculosis Prevention Association, Shenzhen Third people’s hospital |
Registration time: |
2022-03-08 |
Registration number: |
IPGRP-2022CN116 |
Purpose of the guideline: |
Adverse reactions occur from time to time after BCG inoculation and perfusion, but the clinical management of BCG adverse reactions has not been standardized at present, so this guide is formulated to guide medical staff to standardize and reasonably manage BCG adverse reactions. |